Literature DB >> 11589729

Regulation of epidermal growth factor receptor expression in human melanocytes.

C Gordon-Thomson1, R S Mason, G P Moore.   

Abstract

The epidermal growth factor receptor (EGFR) and its ligand, transforming growth factor alpha (TGFalpha), are reportedly involved in autocrine growth of melanoma cells. The signal pathway has also been implicated in early events of transformation, suggesting a function for EGFR in normal cells. This study reports the presence of EGFR in cultured melanocytes and examines some cellular responses to TGFalpha. Western analysis revealed 170 kDa bands in extracts of cultured neonatal human melanocytes, corresponding to the receptor Mr. Protein expression was more pronounced in cells during active growth. EGFR were less evident in cultures populated predominantly by melanized cells, indicating that receptor expression became reduced in differentiating cells. Immunocytochemistry confirmed these observations and also showed that EGFR reactivity was predominantly localized in the cell body but absent from dendrites. Addition of TGFalpha to early cultures induced a rapid increase in phosphotyrosine signal of the 170 kDa protein. Longer treatment (24-48 h) increased the intensity of the EGFR signal, suggesting that receptors had been upregulated. However, inclusion of TGFalpha in cultures did not result in an increase in cell numbers when compared to controls. The observations provide evidence of the existence of a receptor-mediated pathway in melanocytes which has transforming potential in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589729     DOI: 10.1034/j.1600-0625.2001.100504.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  Embryonic requirements for ErbB signaling in neural crest development and adult pigment pattern formation.

Authors:  Erine H Budi; Larissa B Patterson; David M Parichy
Journal:  Development       Date:  2008-05-28       Impact factor: 6.868

2.  A phase II study of gefitinib in patients with metastatic melanoma.

Authors:  Sapna P Patel; Kevin B Kim; Nicholas E Papadopoulos; Wen-Jen Hwu; Patrick Hwu; Victor G Prieto; Menashe Bar-Eli; Maya Zigler; Andrey Dobroff; Yulia Bronstein; Roland L Bassett; Anna G Vardeleon; Agop Y Bedikian
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

3.  Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.

Authors:  Tamás Garay; Eszter Molnár; Éva Juhász; Viktória László; Tamás Barbai; Judit Dobos; Karin Schelch; Christine Pirker; Michael Grusch; Walter Berger; József Tímár; Balázs Hegedűs
Journal:  Pathol Oncol Res       Date:  2015-03-09       Impact factor: 3.201

4.  The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin.

Authors:  Wonseon Choi; Rainer Wolber; Wolfram Gerwat; Tobias Mann; Jan Batzer; Christoph Smuda; Hongfang Liu; Ludger Kolbe; Vincent J Hearing
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

5.  Genetics of dark skin in mice.

Authors:  Karen R Fitch; Kelly A McGowan; Catherine D van Raamsdonk; Helmut Fuchs; Daekee Lee; Anne Puech; Yann Hérault; David W Threadgill; Martin Hrabé de Angelis; Gregory S Barsh
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

Review 6.  Melanogenic Difference Consideration in Ethnic Skin Type: A Balance Approach Between Skin Brightening Applications and Beneficial Sun Exposure.

Authors:  Ewa Markiewicz; Olusola Clement Idowu
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.